Kringle Pharma, Inc. Price (4884.T)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

6,399,270

(18.7203)%

Kringle Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Kringle Pharma, Inc. engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Ibaraki, Japan. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $471-1328
  • Market Cap 5.78B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Mr. Kiichi Adachi Ph.D.
  • IPO Date: December, 28, 2020
  • Country: JP
  • Currency: JPY
  • Headquaters: No Data
  • Employees: 15

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation